{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:39:30Z","timestamp":1790357970488,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jpsychires.2024.11.006","type":"journal-article","created":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T22:02:58Z","timestamp":1730757778000},"page":"382-386","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Defining treatment response in gambling disorder"],"prefix":"10.1016","volume":"180","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7784-7021","authenticated-orcid":false,"given":"Jon E.","family":"Grant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1537-5425","authenticated-orcid":false,"given":"Konstantinos","family":"Ioannidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel R.","family":"Chamberlain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2024.11.006_bib1","series-title":"Diagnostic and Statistical Manual of Mental, Disorders: Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"issue":"3","key":"10.1016\/j.jpsychires.2024.11.006_bib2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/hup.2526","volume":"31","author":"Bobo","year":"2016","journal-title":"Hum. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.jpsychires.2024.11.006_bib3","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1177\/0004867415575774","article-title":"Prevalence of psychiatric co-morbidity in treatment-seeking problem gamblers: a systematic review and meta-analysis","volume":"49","author":"Dowling","year":"2015","journal-title":"Aust. N. Z. J. Psychiatr."},{"issue":"9","key":"10.1016\/j.jpsychires.2024.11.006_bib4","article-title":"Pharmacological interventions for the treatment of disordered and problem gambling","volume":"9","author":"Dowling","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.jpsychires.2024.11.006_bib5","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1192\/bjp.bp.108.062414","article-title":"Imaginal desensitisation plus motivational interviewing for pathological gambling: randomised controlled trial","volume":"195","author":"Grant","year":"2009","journal-title":"Br. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychires.2024.11.006_bib6","first-page":"3","article-title":"A 6-month follow-up of imaginal desensitization plus motivational interviewing in the treatment of pathological gambling","volume":"23","author":"Grant","year":"2011","journal-title":"Ann. Clin. Psychiatr."},{"issue":"4","key":"10.1016\/j.jpsychires.2024.11.006_bib7","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/01.yic.0000073881.93678.21","article-title":"Paroxetine treatment of pathological gambling: a multi-centre randomized controlled trial","volume":"18","author":"Grant","year":"2003","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.jpsychires.2024.11.006_bib8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.psychres.2004.05.006","article-title":"Preliminary validity and reliability testing of a structured clinical interview for pathological gambling","volume":"128","author":"Grant","year":"2004","journal-title":"Psychiatr. Res."},{"issue":"4","key":"10.1016\/j.jpsychires.2024.11.006_bib9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00004850-200607000-00002","article-title":"Escitalopram treatment of pathological gambling with co-occurring anxiety: an open-label pilot study with double-blind discontinuation","volume":"21","author":"Grant","year":"2006","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.jpsychires.2024.11.006_bib10","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.biopsych.2006.11.021","article-title":"N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study","volume":"62","author":"Grant","year":"2007","journal-title":"Biol. Psychiatr."},{"issue":"5","key":"10.1016\/j.jpsychires.2024.11.006_bib11","doi-asserted-by":"crossref","first-page":"783","DOI":"10.4088\/JCP.v69n0511","article-title":"A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges","volume":"69","author":"Grant","year":"2008","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.jpsychires.2024.11.006_bib12","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00213-010-1994-5","article-title":"Memantine shows promise in reducing gambling severity and cognitive inflexibility in pathological gambling: a pilot study","volume":"212","author":"Grant","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"issue":"11","key":"10.1016\/j.jpsychires.2024.11.006_bib13","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.euroneuro.2013.07.008","article-title":"A proof of concept study of tolcapone for pathological gambling: relationships with COMT genotype and brain activation","volume":"23","author":"Grant","year":"2013","journal-title":"Eur. Neuropsychopharmacol"},{"issue":"1","key":"10.1016\/j.jpsychires.2024.11.006_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4088\/JCP.13m08411","article-title":"A randomized, placebo-controlled trial of N-acetylcysteine plus imaginal desensitization for nicotine-dependent pathological gamblers","volume":"75","author":"Grant","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2024.11.006_bib15","series-title":"ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: US Department of Heath, Education, and Welfare Public Health Service Alcohol, Drug Abuse, and Mental Health Administration","year":"1976"},{"issue":"9806","key":"10.1016\/j.jpsychires.2024.11.006_bib16","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/S0140-6736(10)62185-X","article-title":"Gambling disorders","volume":"378","author":"Hodgins","year":"2011","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.jpsychires.2024.11.006_bib17","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1176\/ajp.155.12.1781","article-title":"Short-term single-blind fluvoxamine treatment of pathological gambling","volume":"155","author":"Hollander","year":"1998","journal-title":"Am. J. Psychiatr."},{"issue":"6","key":"10.1016\/j.jpsychires.2024.11.006_bib18","doi-asserted-by":"crossref","first-page":"784","DOI":"10.4088\/JCP.09m05911blu","article-title":"Quality of life outcomes in patients with obsessive-compulsive disorder: relationship to treatment response and symptom relapse","volume":"71","author":"Hollander","year":"2010","journal-title":"J. Clin. Psychiatry"},{"issue":"20","key":"10.1016\/j.jpsychires.2024.11.006_bib19","article-title":"Pharmacological management of gambling disorder: a systematic review and network meta-analysis","volume":"10","author":"Ioannidis","year":"2023","journal-title":"medRxiv"},{"issue":"5","key":"10.1016\/j.jpsychires.2024.11.006_bib20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00004850-200109000-00006","article-title":"An open naltrexone treatment study in pathological gambling disorder","volume":"16","author":"Kim","year":"2001","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"11","key":"10.1016\/j.jpsychires.2024.11.006_bib21","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0006-3223(01)01079-4","article-title":"Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling","volume":"49","author":"Kim","year":"2001","journal-title":"Biol. Psychiatr."},{"issue":"6","key":"10.1016\/j.jpsychires.2024.11.006_bib22","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4088\/JCP.v63n0606","article-title":"A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling","volume":"63","author":"Kim","year":"2002","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychires.2024.11.006_bib23","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.psychres.2007.11.008","article-title":"The gambling symptom assessment scale (G-SAS): a reliability and validity study","volume":"166","author":"Kim","year":"2009","journal-title":"Psychiatr. Res."},{"issue":"2","key":"10.1016\/j.jpsychires.2024.11.006_bib24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1017\/S1461145702002900","article-title":"Treatment non-response in OCD: methodological issues and operational definitions","volume":"5","author":"Pallanti","year":"2002","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.jpsychires.2024.11.006_bib25","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10899-005-5557-3","article-title":"Reliability and validity of the pathological gambling adaptation of the Yale-Brown obsessive-compulsive scale (PG-YBOCS)","volume":"21","author":"Pallanti","year":"2005","journal-title":"J. Gambl. Stud."},{"issue":"4","key":"10.1016\/j.jpsychires.2024.11.006_bib26","first-page":"250","article-title":"The effectiveness of a cognitive-behavioral intervention for pathological gambling: a country-wide study","volume":"25","author":"Pasche","year":"2013","journal-title":"Ann. Clin. Psychiatr."},{"key":"10.1016\/j.jpsychires.2024.11.006_bib27","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/add.13968","article-title":"Measuring treatment outcomes in gambling disorders: a systematic review","volume":"113","author":"Pickering","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.jpsychires.2024.11.006_bib28","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jpsychires.2024.03.044","article-title":"An evaluation of treatment response and remission definitions in adult obsessive- compulsive disorder: a systematic review and individual-patient data meta-analysis","volume":"173","author":"Ramakrishnan","year":"2024","journal-title":"J. Psychiatr. Res."},{"issue":"12","key":"10.1016\/j.jpsychires.2024.11.006_bib29","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.4088\/JCP.v66n1209","article-title":"Defining response in clinical trials for obsessive- compulsive disorder: a signal detection analysis of the Yale-Brown obsessive compulsive scale","volume":"66","author":"Tolin","year":"2005","journal-title":"J. Clin. Psychiatry"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395624006265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395624006265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T18:41:36Z","timestamp":1736275296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395624006265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":29,"alternative-id":["S0022395624006265"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2024.11.006","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defining treatment response in gambling disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2024.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}